Cervical cancer risk with the use of tumour necrosis factor inhibitors in rheumatoid arthritis : to worry or not to worry?
Clinical trials of new drugs for the treatment of rheumatoid arthritis : focus on early disease
Do RA or TNF inhibitors increase the risk of cervical neoplasia or of recurrence of previous neoplasia? A nationwide study from Sweden
Endometriosis and the risks of systemic lupus erythematosus and rheumatoid arthritis in the Nurses’ Health Study II
Incidence and predictors of cutaneous manifestations during the early course of systemic sclerosis : a 10-year longitudinal study from the EUSTAR database
Efficacy and safety of tofacitinib following inadequate response to conventional synthetic or biological disease-modifying antirheumatic drugs
A psychometric analysis of outcome measures in peripheral spondyloarthritis
Patients with chronic back pain of short duration from the SPACE cohort : which MRI structural lesions in the sacroiliac joints and inflammatory and structural lesions in the spine are most specific for axial spondyloarthritis?
Statin use and mortality in rheumatoid arthritis : a general population-based cohort study
Comparison of the efficacies of abatacept and tocilizumab in patients with rheumatoid arthritis by propensity score matching
Clinical and MRI responses to etanercept in early non-radiographic axial spondyloarthritis : 48-week results from the EMBARK study
Effectiveness of tocilizumab with and without synthetic disease-modifying antirheumatic drugs in rheumatoid arthritis : results from a European collaborative study
A patient-initiated DMARD self-monitoring service for people with rheumatoid or psoriatic arthritis on methotrexate : a randomised controlled trial
Outcomes of percutaneous coronary intervention in patients with rheumatoid arthritis and systemic lupus erythematosus : an 11-year nationwide cohort study
Elevated calprotectin levels reveal bowel inflammation in spondyloarthritis
Hyperuricaemia : contributions of urate transporter ABCG2 and the fractional renal clearance of urate
Transitions to different patterns of interstitial lung disease in scleroderma with and without treatment
Interleukin-6 and chondrocyte mineralisation act in tandem to promote experimental osteoarthritis
Whole-genome single nucleotide polymorphism-based linkage analysis in spondyloarthritis multiplex families reveals a new susceptibility locus in 13q13
MICL controls inflammation in rheumatoid arthritis
Acute serum amyloid A is an endogenous TLR2 ligand that mediates inflammatory and angiogenic mechanisms
Efficient therapy of ischaemic lesions with VEGF121-fibrin in an animal model of systemic sclerosis
Low-dose interleukin-2 selectively corrects regulatory T cell defects in patients with systemic lupus erythematosus
Replication of a distinct psoriatic arthritis risk variant at the IL23R locus
Evidence of response to IL-6 inhibition in some cases of refractory spondyloarthritis-associated peripheral synovitis
Negative association between autoantibodies against IL-17, IL-17/anti-IL-17 antibody immune complexes and destruction in rheumatoid arthritis
Correction : Association of the programmed death 1 gene polymorphism with the development of rheumatoid arthritis in the population of South-Eastern Poland
Correction : Delays in assessment of patients with rheumatoid arthritis
Evidence for treating rheumatoid arthritis to target : results of a systematic literature search update
Response to : ‘Evidence for treating rheumatoid arthritis to target
Comparing the immunogenicity of the etanercept biosimilar SB4 with the innovator etanercept : another consideration
Response to : ‘Comparing the immunogenicity of the etanercept biosimilar SB4 with the innovator etanercept
Anti Etanercept and anti SB4 antibodies detection : impact of the assay method
Confirmation on the immunogenicity assay used in the SB4 phase III study : response to the comments by Meacci et al
Low dose of fish oil in osteoarthritis : low effect?
Fish oil for OA? Don't give up yet
Did the subjects and the controls have the same disease?
Should 2016 Criteria for Macrophage Activation Syndrome be applied in children with Kawasaki disease, as well as with systemic-onset juvenile idiopathic arthritis?
Can genetics explain the higher risk of worsening knee pain in offspring of people with total knee replacement for severe primary knee osteoarthritis?
Correction : Discontinuation of adalimumab after achieving remission in patients with established rheumatoid arthritis